Success Stories: NAILG Secures Swift EB2-NIW Approval for a Chinese PhD Candidate Advancing AI in Drug Development
On May 14th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a PhD Candidate in the Field of Artificial Intelligence for Drug Development (Approval Notice).
General Field: Artificial Intelligence for Drug Development
Position at the Time of Case Filing: PhD Candidate
Country of Origin: China
State of Residence at the time of filing: Georgia
Approval Notice Date: May 14th, 2025
Processing Time: 2 months and 7 days (Premium Processing Requested)
Case Read more [...]